Malaysia Launches National Policy as Over 12,000 Patients Battle Rare Diseases Nationwide
KUALA LUMPUR: More than 12,000 Malaysians are currently undergoing treatment for rare diseases at public hospitals, involving nearly 500 different conditions, highlighting the growing need for a stronger and more inclusive healthcare framework.
Health Minister Dzulkefly Ahmad said the figures reflect the urgent necessity to enhance policies, funding mechanisms and support systems for patients who are often overlooked.
He stressed that the true strength of a healthcare system lies not in how well it serves the strongest members of society, but in how it protects the most vulnerable.
“In Southeast Asia alone, more than 45 million people are estimated to be living with rare diseases. In Malaysia, over 12,000 patients are receiving treatment for nearly 500 conditions,” he said at the launch of the National Policy for Rare Diseases.
Global Challenges and Limited Treatment Options
Dzulkefly noted that globally, almost 8,000 rare diseases have been identified, yet only around 500 have specific treatments available.
This limitation forces many patients to rely on long-term supportive care, specialised nutrition and symptom management, often at high financial cost.
“Many patients wait years for accurate diagnosis, while others struggle to access specialised treatment,” he said.
Expanding Financial Support
The minister welcomed the additional RM5 million allocation approved by state governments to support rare disease treatment.
However, he emphasised that more resources are needed to meet the actual demands nationwide.
“I will continue to advocate for increased funding throughout my tenure. Support for rare disease patients cannot rely solely on government funds,” he said.
He also encouraged philanthropic organisations, corporations and individuals to contribute to sustainable healthcare financing.
Three Key Pillars of the National Policy
The newly launched policy is built on three main pillars.
The first focuses on strengthening clinical governance to ensure systematic and high-quality patient management.
The second aims to improve early and accurate diagnosis through enhanced screening and specialist training.
The third pillar prioritises expanding access to treatment, including specialised medicines, nutritional therapy and social support.
“This pillar adopts a comprehensive, multi-stakeholder approach,” he explained.
Whole-of-Nation Collaboration
Dzulkefly emphasised that rare disease management requires a whole-of-nation strategy involving multiple ministries and agencies.
Key stakeholders include education providers, social welfare departments, research institutions and community organisations.
“The Health Ministry cannot address this alone. It requires cross-ministerial cooperation and societal participation,” he said.
Strengthening Continuity of Care
He also highlighted the importance of improving continuity of care from hospitals to community-based services.
Patients must receive long-term monitoring, rehabilitation support and psychosocial assistance after discharge.
“Our aim is to ensure uninterrupted care and better quality of life for patients,” he said.
Long-Term Government Commitment
The policy launch represents a significant milestone in building a more inclusive and compassionate healthcare system.
The government is committed to ensuring that rare disease patients are no longer marginalised and receive equitable access to care.
“This policy reflects our moral responsibility to protect every Malaysian, regardless of how rare their condition may be,” he added.
-wilayah.com.my
